Taysha Gene Therapies, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 263.7M |
| FY2023 | 232.2M |
| FY2024 | 250.1M |
| FY2025 | 319.7M |
| FY2026 | 287.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 263.7M |
| FY2023 | 232.2M |
| FY2024 | 250.1M |
| FY2025 | 319.7M |
| FY2026 | 287.3M |